TY  - GEN
AU  - Jimeno,Antonio
AU  - Weiss,Glen J
AU  - Miller,Wilson H
AU  - Gettinger,Scott
AU  - Eigl,Bernard J C
AU  - Chang,Anne Lynne S
AU  - Dunbar,Joi
AU  - Devens,Shannon
AU  - Faia,Kerrie
AU  - Skliris,Georgios
AU  - Kutok,Jeff
AU  - Lewis,Karl D
AU  - Tibes,Raoul
AU  - Sharfman,William H
AU  - Ross,Robert W
AU  - Rudin,Charles M
TI  - Phase I study of the Hedgehog pathway inhibitor IPI-926 in adult patients with solid tumors
SN  - 1557-3265
PY  - 2013///1216
KW  - Adult
KW  - Aged
KW  - Aged, 80 and over
KW  - Alanine Transaminase
KW  - metabolism
KW  - Alopecia
KW  - chemically induced
KW  - Area Under Curve
KW  - Aspartate Aminotransferases
KW  - Dose-Response Relationship, Drug
KW  - Drug Administration Schedule
KW  - Fatigue
KW  - Female
KW  - Follow-Up Studies
KW  - Hedgehog Proteins
KW  - Humans
KW  - Male
KW  - Metabolic Clearance Rate
KW  - Middle Aged
KW  - Nausea
KW  - Neoplasms
KW  - drug therapy
KW  - Signal Transduction
KW  - drug effects
KW  - Spasm
KW  - Treatment Outcome
KW  - Veratrum Alkaloids
KW  - adverse effects
N1  - Publication Type: Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1158/1078-0432.CCR-12-3654
ER  -